Semaglutide vs. Tirzepatide: Efficacy, Mechanism, and Weight Loss Differences
Written by Dan Cripe, RN, BSN & Marcia Cripe, RN | Last Updated: September 16, 2026
Medical Note
This article is
Wegovy: Semaglutide for Chronic Weight Management
Written by Dan Cripe, RN, BSN & Marcia Cripe, RN | Last Updated: September 16, 2026
Medical Note
This article is
Ozempic vs. Wegovy: Same Molecule, Different Dosages and Approvals
Written by Dan Cripe, RN, BSN & Marcia Cripe, RN | Last Updated: September 15, 2026
Medical Note
This article is
Ozempic: Semaglutide for Type 2 Diabetes
Written by Dan Cripe, RN, BSN & Marcia Cripe, RN | Last Updated: September 15, 2026
Medical Note
This article is
The Complete GLP-1 Dosing Ladder: Starter, Intermediate, and Maximum Tiers
Written by Dan Cripe, RN, BSN & Marcia Cripe, RN | Last Updated: September 27, 2026
Medical Note
This article is
How GLP-1 Works: A Plain-Language Science Guide
Two registered nurses explain what GLP-1 medications actually do inside your body—from pancreas and gut signals to brain appetite and reward circuits.
How GLP-1 Receptor Agonists Work: The Science of Incretin Mimetics
Written by Dan Cripe, RN, BSN & Marcia Cripe, RN | Last Updated: September 13, 2026
Medical Note
This article is
Oral GLP-1 vs. Weekly Injection: How to Choose the Right Delivery Method
A GLP-1 pill avoids the needle—but may require a strict daily fasting routine. A weekly injection requires a shot but offers more freedom from daily medication timing. Here’s how to decide which route actually fits your life.
Why Does Adderall Feel Different on a GLP-1? What We Know—and What We Don’t
Does Adderall suddenly take longer to kick in—or feel weaker or less predictable—after starting a GLP-1? Slower gastric emptying makes a change in oral medication timing plausible, but the Adderall-specific evidence is still limited.
Amycretin Pill vs Orforglipron: Which Oral Drug Has Better Weight-Loss Trial Results?
Oral amycretin produced striking early weight-loss results, while orforglipron has a much larger Phase 3 evidence base and is already FDA-approved. The numbers make amycretin look stronger at first glance, but the trials are too different to declare a winner yet.